Antiandrogens are medications that block androgens like testosterone and dihydrotestosterone (DHT) from mediating their biological effects in the body. Men with prostate cancer, benign prostatic hyperplasia, pattern hair loss, hypersexuality, paraphilias, and priapism are treated with antiandrogens. Antiandrogens are used to treat acne, seborrhea, hirsutism, and hyperandrogenism in women and girls.
For metastatic prostate cancer, Antiandrogen Monotherapy is an alternative to androgen-deprivation therapy (ADT) with surgical or pharmacological castration. Castration for metastatic prostate cancer, whether surgical or pharmaceutical, is associated with a loss of libido and impotence, which is not always acceptable to the patient. As a result, antiandrogen monotherapy offers a viable alternative to castration in the treatment of prostate cancer, boosting the antiandrogen monotherapy market over the projection period.
Read More@ https://bit.ly/3G0atF4
